Aspirin May Help Prevent Skin Cancer
Get the world’s most fascinating discoveries delivered straight to your inbox.
You are now subscribed
Your newsletter sign-up was successful
Want to add more newsletters?
Delivered Daily
Daily Newsletter
Sign up for the latest discoveries, groundbreaking research and fascinating breakthroughs that impact you and the wider world direct to your inbox.
Once a week
Life's Little Mysteries
Feed your curiosity with an exclusive mystery every week, solved with science and delivered direct to your inbox before it's seen anywhere else.
Once a week
How It Works
Sign up to our free science & technology newsletter for your weekly fix of fascinating articles, quick quizzes, amazing images, and more
Delivered daily
Space.com Newsletter
Breaking space news, the latest updates on rocket launches, skywatching events and more!
Once a month
Watch This Space
Sign up to our monthly entertainment newsletter to keep up with all our coverage of the latest sci-fi and space movies, tv shows, games and books.
Once a week
Night Sky This Week
Discover this week's must-see night sky events, moon phases, and stunning astrophotos. Sign up for our skywatching newsletter and explore the universe with us!
Join the club
Get full access to premium articles, exclusive features and a growing list of member rewards.
Aspirin and other similar anti-inflammatory painkillers such as ibuprofen and naproxen can lessen the risk of three major types of skin cancer, a new study suggests.
Researchers studied medical records from northern Denmark from 1991 through 2009, finding 3,242 diagnoses of malignant melanoma, the deadliest form of skin cancer, along with 1,974 diagnoses of squamous cell carcinoma, and 13,316 diagnoses of basal cell carcinoma. The study also analyzed prescription data from these patients and information from 178,655 individuals without skin cancer.
Individuals who filled more than two prescriptions for nonsteroidal anti-inflammatory drugs (NSAIDs) had a 15 percent lower risk for developing squamous cell carcinoma and a 13 percent decreased risk for developing malignant melanoma than those who filled two or fewer prescriptions for the medications, especially when the drugs were taken for seven or more years or taken at high intensity.
"We hope that the potential cancer-protective effect of NSAIDs will inspire more research on skin cancer prevention," said study researcher Sigrún Alba Jóhannesdóttir of Aarhus University Hospital in Denmark. "Also, this potential cancer-protective effect should be taken into account when discussing benefits and harms of NSAID use."
People who took NSAIDs did not seem to benefit from a reduced risk of developing basal cell carcinoma in general, although they did have a 15 percent and 21 percent reduced risk of developing this type of cancer on less-exposed sites (body areas other than the head and neck) when they took them long term or at high intensity, respectively.
The results are detailed in Cancer, a journal of the American Cancer Society.
Get the world’s most fascinating discoveries delivered straight to your inbox.

